About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in California | 676 Studies

Clinical Trials Pancreatic CancerCalifornia

Pancreatic Cancer Clinical Trials in California

Find 676 clinical trials for pancreatic cancer near California. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 341-360 of 676 trials

RecruitingcfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseThis is an observational case-control study to train and validate a genome-wide methylome enrichment platform to detect multiple cancer types and to differentiate amongst cancer…NCT05366881·Duarte, California and 16 others CompletedMedical Food for the Dietary Management of Advanced/Metastatic Pancreatic CancerThis is a single arm study evaluating the tolerability and markers of pancreatic cancer with a specially designed medical food restricted in specific amino acids for the dietary…NCT05078775·Tucson, Arizona and 8 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsThe primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants with previously treated, unresectable, locally advanced or…NCT06943755·Birmingham, Alabama and 125 others

CompletedFATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid TumorsThis is a Phase 1, single-dose, open-label, dose-escalation study.NCT03319459·San Diego, California and 3 others

Active not recruitingPhase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid TumorsThis is a nonrandomized, uncontrolled, open-label, multicenter Phase 2 study to evaluate the efficacy, safety, and tolerability of futibatinib in combination with PD-1…NCT05945823·Santa Monica, California and 21 others

CompletedA Study of IMM-6-415 in RAS/RAF Mutant Solid TumorsThis is a FIH, ascending dose study to characterize the safety, tolerability, optimal dose and preliminary anti-tumor activity of IMM-6-415 in participants with advanced or…NCT06208124·Scottsdale, Arizona and 4 others

UnknownCAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsPhase 1, first-in-human, open label study of CAR macrophages in HER2 overexpressing solid tumors.NCT04660929·Duarte, California and 6 others

UnknownA Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid TumorsA Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™Capsules given daily for 21 days followed by 7 days off…NCT03129139·Birmingham, Alabama and 6 others

CompletedA Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid TumorsStudy CP-MGC018-02 is a study of vobramitamab duocarmazine (MGC018) in combination with lorigerlimab (MGD019).NCT05293496·Los Angeles, California and 9 others

CompletedPalliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic CancerThis pilot clinical trial studies a palliative care program in improving the quality of life of patients with newly diagnosed pancreatic cancer.NCT02307539·Duarte, California

TerminatedPrognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical ResectionThe purpose of this study is first, to determine whether baseline perfusion characteristics of pancreatic cancer, as characterized by CT perfusion studies, can predict tumor…NCT01326364·Stanford, California

CompletedNab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)The purpose of this study is to compare whether there is a delay or prevention of recurrence or death in participants with surgically removed pancreatic cancer who then take…NCT01964430·Scottsdale, Arizona and 340 others

TerminatedSafety Study of CALAA-01 to Treat Solid Tumor CancersRationale: CALAA-01 is a targeted therapeutic designed to inhibit tumor growth and/or reduce tumor size. The active ingredient in CALAA-01 is a small interfering RNA (siRNA).NCT00689065·Duarte, California and 2 others

Active not recruitingElectron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular InvolvementThis research study is studying an intervention as a possible treatment for pancreatic cancer.NCT03716531·Irvine, California and 5 others

RecruitingPancreatic Cancer Early Detection ConsortiumThe purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal…NCT04970056·Phoenix, Arizona and 59 others

CompletedA Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advanced GI malignancies.NCT05039177·Birmingham, Alabama and 13 others

CompletedTrial of NanoPac® in Subjects With Locally Advanced Pancreatic AdenocarcinomaOpen-label, dose-escalating, Phase IIa trial of NanoPac® to treat subjects with locally advanced pancreatic adenocarcinoma via direct intratumoral injection.NCT03077685·Los Angeles, California and 3 others

CompletedNivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic CancerThis pilot and feasibility study studies how well nivolumab and combination chemotherapy work before surgery in treating patients with pancreatic cancer that could possibly be…NCT03970252·Los Angeles, California

RecruitingDistance-Based Exercise to Preserve Function and Prevent DisabilityThis clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to…NCT07059884·Dublin, California and 17 others

TerminatedA Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid TumorsThe primary objective of this study is to identify the recommended phase 2 dose (RP2D) and/or the maximum tolerated dose (MTD), and characterize the safety and tolerability of…NCT05389462·Santa Monica, California and 13 others

PreviousPage 18 of 34Next

Other Conditions in California

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia